Small humanin-like peptide 2
Small humanin-like peptide 2 has been studied in 1 paper since 2022: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Jan 31, 2022: “Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition”.
1 paper studies it1 findingUpdated
What did studies of Small humanin-like peptide 2 find?
1Studies of Small humanin-like peptide 2 measured 1 outcome; the most studied are Parkinson's disease (1 study).
Parkinson's disease
downin reviews1
1 study
Parkinson's disease
downin reviews1
Small humanin-like peptide 2 protects against Parkinson's disease.
“Small humanin-like peptide 2 demonstrates the neuroprotective effects in PD and AMD via prevention of mitochondrial loss.”
Review
Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition
Biochimica et biophysica acta. General subjects
Latest
Biochimica et Biophysica Acta General Subjects